Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 581 of 1,261
  1. US 9895435

    Vaccines for HSV-2

    IMMUNE DESIGN CORP. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  2. US 9895429

    Antibodies that bind amyloid oligomers

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  3. US 9896437

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  4. US 9895414

    Inhibition of cancer growth and metastasis

    ABREGEN PTY LTD · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  5. US 9895396

    Citrate containing beverage

    The Regents of the University of California · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  6. US 9895359

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  7. US 9895328

    Calcium formate as a supplement to prevent neural tube defects

    The Board of Regents of the University of Texas System · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  8. US 9889081

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  9. US 9890487

    Liquid-retaining sheet and facial mask

    KURARAY KURAFLEX CO., LTD. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  10. US 9890379

    Treatment of genetic disorders associated with DNA repeat instability

    BIOMARIN TECHNOLOGIES B.V. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  11. US 9890216

    Antibodies with engineered IgG Fc domains

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  12. US 9890369

    Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  13. US 9890362

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  14. US 9890221

    Cellulose ethers esterified with dicarboxylic acid

    Regents of the University of Minnesota · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  15. US 9890176

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  16. US 9890211

    Antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  17. US 9890210

    Antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  18. US 9890145

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  19. US 9890126

    Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

    Beryllium Discovery Corp. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  20. US 9889211

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  21. US 9890117

    Benzamide compounds and related methods of use

    Northwestern University · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  22. US 9889230

    Hemostatic implant

    Covidien LP · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  23. US 9890144

    Compounds and method for treating autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  24. US 9889161

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.